You might know you need to conduct drug metabolism and pharmacokinetic (DMPK) analysis, but which tests are right for your project? And are you doing them at the right time? When building your preclinical strategy, these questions matter—and that’s true now more than ever, as new drug classes and targets emerge.
September 30, 2020
- Featured Guest Blog: Quality is Critical by Mary E. Lynn
- Creating Consistent Results by Managing your Flow Cytometry Data
- Comparison of Different Fix/Permeabilization Buffers for use in Flow Cytometry Evaluations
- Quantification of Regulatory T Cells in Mouse Tumor Specimens Using Flow Cytometry
- A Science Driven Approach: Translating Preclinical ADC Insights into Clinical Success
Featured Guest Blog: Quality is Critical by Mary E. Lynn
By Mary E. Lynn, MS, RQAP-GLP, Registered Quality Assurance Professional
Creating Consistent Results by Managing your Flow Cytometry Data
By Jennifer J. Stewart, PhD
Comparison of Different Fix/Permeabilization Buffers for use in Flow Cytometry Evaluations
By Jayne Schaubhut, Lab Supervisor
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.
